Roche announced today it will invest CHF 450 million over the next three years to establish a new diagnostic manufacturing facility at the Suzhou Industrial Park, in Suzhou, China. The new manufacturing site sets out to address the continuously growing demand for diagnostic tests in China and the Asia Pacific region. As a new addition to RocheÕs global diagnostic production network, the Asia manufacturing facility will focus on producing Immunochemistry and Clinical Chemistry tests, products that are crucial to clinical laboratory testing. The site plans to build a workforce of over 600 employees over the next several years.